Paper Details

  1. Home
  2. Paper Details

Emerging therapies for chronic migraine.

Author: GrazziLicia, Proietti CecchiniAlberto

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Chronic migraines that aren't caused by overuse of medication can be difficult to treat. While some medications are available, they can be ineffective or have unwanted side effects. New treatments for chronic migraines are needed. Recent research suggests that occipital nerve stimulation (ONS) and injections of botulinum toxin type A can help, with at least some improvement seen in many patients. More research is needed to identify the best candidates for these treatments.
Paper Details　
Original Abstract of the Article :
Not all chronic migraines are medication-overuse headaches and so the challenge is how to treat them. Currently available pharmacological therapies may be ineffective or they are abandoned because of intolerable side effects. There is still much room for novel therapeutic approaches in those with dr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s11916-014-0408-5

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Chronic Migraine: Emerging Therapies

The [neuroscience] landscape is a fascinating blend of complexity and mystery, and [migraine] is a condition that has long posed challenges for researchers. This study explores the landscape of [chronic migraine], a condition that can be debilitating and resistant to conventional therapies. It’s like a relentless sandstorm in the desert, leaving sufferers seeking relief.

This research examines the potential of [emerging therapies] for [drug-refractory migraine (RM)], such as [occipital nerve stimulation (ONS)] and [botulinum toxin type A]. The authors delve into the complexities of this condition, presenting a compelling case for these novel therapeutic approaches. They highlight the need for careful patient selection when considering these treatments, much like choosing the best route through a treacherous desert.

Hope on the Horizon for Chronic Migraine

This study suggests that [ONS] and [botulinum toxin type A] might offer valuable relief for individuals struggling with [RM]. The results, like oases in the desert, provide a glimmer of hope for those seeking relief from this debilitating condition. The researchers advocate for careful patient selection to maximize the chances of success, ensuring that these treatments are used effectively.

Living with Migraine: A Desert Journey

Migraine sufferers often find themselves navigating a desert of pain, discomfort, and uncertainty. This research offers a potential path forward, suggesting that [ONS] and [botulinum toxin type A] could provide a much-needed respite from the relentless storms. It's a reminder that even in the face of adversity, there is always hope for a brighter future.

Dr. Camel's Conclusion

This research is a vital step forward in the quest to understand and manage [chronic migraine]. The potential of [ONS] and [botulinum toxin type A] offers a glimmer of hope, like a shimmering oasis in the vast and often unforgiving desert of [migraine].

Date :
  1. Date Completed 2014-11-10
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24523001

DOI: Digital Object Identifier

10.1007/s11916-014-0408-5

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.